Compare ADMA Biologics Inc (ADMA) vs Sony Group Corp (SONY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Sony Group Corp — how do they compare? ADMA Biologics Inc trades at $9.87 (market cap $2.22B), while Sony Group Corp trades at $23.69 (market cap $138.43B). The key difference: Sony Group Corp is far larger — about 62.4× ADMA Biologics Inc's market cap, and Sony Group Corp pays a 0.67% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | SONY | |
|---|---|---|
Market Cap | $2.22B | $138.43B |
Sector | Health | Technology |
52-Week High | $20.38 | $30.26 |
52-Week Low | $7.60 | $19.32 |
Enterprise Value | $2.29B | $136.35B |
Dividend Yield | — | 0.67% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Sony Group Corp
Sony Group is a conglomerate with consumer electronics roots, which not only designs, develops, produces, and sells electronic equipment and devices, but also is engaged in content businesses, such as console and mobile games, music, and movies. Sony is a global top company of CMOS image sensors, game consoles, professional broadcasting cameras, and music publishing, and is one of the top players on digital cameras, wireless earphones, recorded music, movies, and so on. Sony's business portfolio is well diversified with six major business segments. The company fully consolidated Sony Financial in September 2020, which provides life and non-life insurance, banking, and other financial services.
Read more on SONY →
